Bill Lundberg

Bill Lundberg

Chief Executive Officer bij MERUS N.V.

Vermogen: 7 M $ op 29-02-2024

60 jaar
Health Technology
Consumer Services
Finance

Profiel

Presently, Sven Ante Lundberg is President, CEO & Executive Director at Merus NV.
He is also on the board of Vor Biopharma, Inc., Q32 Bio, Inc. (Massachusetts) and Q32 Bio, Inc. In the past he held the position of Chief Scientific Officer of CRISPR Therapeutics AG, Medical Director for Wyeth LLC, Medical Director at Genzyme Corp., Director & Chief Medical Officer at Taligen Therapeutics, Inc., Vice President & Head-Translational Medicine at Alexion Pharmaceuticals, Inc., Principal at Antisoma Research Ltd., Vice President-Clinical Development at Sarossa Capital Ltd.
and Principal at Antisoma, Inc. Sven Ante Lundberg received a doctorate from Stanford University School of Medicine, an MBA from The Isenberg School of Management, an MBA from the University of Massachusetts and an undergraduate degree from Massachusetts Institute of Technology.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
14-04-2023 152 071 ( 0.26% ) 7 M $ 29-02-2024
26-05-2023 29 432 ( 0.04% ) 67 694 $ 29-02-2024
0.00%
25-03-2024 1 200 ( 0.00% ) 1 104 $ 29-02-2024

Actieve functies van Bill Lundberg

BedrijvenFunctieBegin
MERUS N.V. Chief Executive Officer 31-12-2019
VOR BIOPHARMA INC. Director/Board Member 31-07-2019
Director/Board Member -
Alle actieve functies van Bill Lundberg

Eerdere bekende functies van Bill Lundberg

BedrijvenFunctieEinde
CRISPR THERAPEUTICS AG Chief Tech/Sci/R&D Officer 08-02-2018
ALEXION PHARMACEUTICALS, INC. Corporate Officer/Principal 01-02-2015
Chief Tech/Sci/R&D Officer 24-02-2012
Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Ervaring van Bill Lundberg in detail bekijken

Opleiding van Bill Lundberg

Massachusetts Institute of Technology Undergraduate Degree
University of Massachusetts Masters Business Admin
Stanford University School of Medicine Doctorate Degree
The Isenberg School of Management Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Bill Lundberg in detail bekijken

Connecties

100 +

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
MERUS N.V.

Health Technology

CRISPR THERAPEUTICS AG

Health Technology

VOR BIOPHARMA INC.

Health Technology

Bedrijven in privébezit9

Health Technology

Health Technology

Health Technology

Antisoma Research Ltd.

Health Technology

Finance

Health Technology

Health Services

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Bill Lundberg